Clene Inc.
$6.15
▲
4.7%
2026-04-21 06:04:01
clene.com
NCM: CLNN
Explore Clene Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$74.32 M
Current Price
$6.15
52W High / Low
$13.5 / $2.28
Stock P/E
—
Book Value
$-1.62
Dividend Yield
—
ROCE
-296.61%
ROE
197.91%
Face Value
—
EPS
$-2.65
Exp Qtr EPS
—
Sector
Consumer Defensive
Industry
Packaged Foods
Employees
76
Beta
0.62
Debt / Equity
-1.23
Current Ratio
0.83
Quick Ratio
0.83
Forward P/E
-4.2
Price / Sales
359.83
Enterprise Value
$88.45 M
EV / EBITDA
-4.1
EV / Revenue
442.25
Rating
None
Target Price
$30.33
EPS Forecast (FY)
—
Pros
- Healthy return on equity.
- Balance sheet leverage appears manageable.
- Valuation is not stretched on P/E basis.
Cons
- Capital efficiency is modest.
- Current ratio suggests tighter short-term liquidity.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Borealis Foods Inc. | $0.93 | — | $20.18 M | — | -58.97% | 229.8% | $7.05 / $0.6 | $-0.6 |
| 2. | Paranovus Entertainment Technology Ltd. | $1.56 | — | $1.64 M | — | -7.88% | -21.54% | $1,680 / $1.56 | $35.33 |
| 3. | Lifeway Foods, Inc. | $26.7 | 28.74 | $398.28 M | — | 18.18% | 17.57% | $34.2 / $17.31 | $5.63 |
| 4. | SRx Health Solutions Inc. | $0.12 | — | $37.87 M | — | -234.74% | 164.52% | $2.16 / $0.08 | $-0.11 |
| 5. | Above Food Ingredients Inc. | $0.71 | — | $51.19 M | — | 396.47% | 244.4% | $6.56 / $0.32 | $-0.43 |
| 6. | Bridgford Foods Corporation | $7.28 | — | $68.89 M | — | -15.01% | -10.83% | $8.74 / $7 | $12.64 |
| 7. | Beyond Meat, Inc. | $1.16 | 2.48 | $537.73 M | — | -25.32% | 28.76% | $7.69 / $0.5 | $0 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 0.08 M | 0.01 M | 0.03 M | 0.08 M | 0.09 M | — |
| Operating Profit | -7.24 M | -5.37 M | -5.63 M | -3.57 M | -8.44 M | — |
| Net Profit | -9.23 M | -8.78 M | -7.42 M | -0.75 M | -13.55 M | — |
| EPS in Rs | -0.78 | -0.75 | -0.63 | -0.06 | -1.15 | -1.22 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 0.2 M | 0.34 M | 0.65 M | 0.47 M |
| Operating Profit | -21.82 M | -31.98 M | -38.26 M | -44.56 M |
| Net Profit | -26.17 M | -39.4 M | -49.5 M | -29.92 M |
| EPS in Rs | -2.22 | -3.35 | -4.2 | -2.54 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 18.13 M | 27.34 M | 52.34 M | 44.49 M |
| Total Liabilities | 35.72 M | 36.19 M | 38.95 M | 41.26 M |
| Equity | -17.59 M | -8.86 M | 13.39 M | 3.24 M |
| Current Assets | 8.98 M | 16.16 M | 38.85 M | 29.2 M |
| Current Liabilities | 10.78 M | 10.29 M | 25.33 M | 13.86 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -18.55 M | -21.33 M | -30.17 M | -39.01 M |
| Investing CF | -0.04 M | 6.32 M | -1.5 M | -10.16 M |
| Financing CF | 11.52 M | -1.53 M | 42.16 M | 17.25 M |
| Free CF | -18.59 M | -21.34 M | -30.5 M | -44.19 M |
| Capex | -0.04 M | -0.01 M | -0.33 M | -5.18 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | -47.71% | 38.27% | — | — |
| Earnings Growth % | 20.41% | -65.47% | — | — |
| Profit Margin % | -11520.47% | -7569.42% | -6325.16% | — |
| Operating Margin % | -9349.42% | -5850.15% | -9420.08% | — |
| Gross Margin % | 79.53% | 81.5% | 94.5% | — |
| EBITDA Margin % | -9851.17% | -6611.77% | -5412.9% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2024-07-11 | 1:0.05 |